V. Pezzella

The tumor burden of metastatic colorectal cancer patients at initial diagnosis, pre- versus post-Covid-19 lockdown

M. Ychou, E. Assenat, D. Smith, 2021, medRxiv.

Renal insufficiency, mortality, and drug management in heart transplant. Results of the CARIN study

A. Pavie, S. Varnous, R. Guillemain, 2014, Transplant international : official journal of the European Society for Organ Transplantation.

Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy – a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol

T. de Baère, C. Dromain, V. Boige, 2020, BMC Cancer.

An open-label, phase II study of rucaparib, a PARP inhibitor, in HER2- metastatic breast cancer patients with high genomic loss of heterozygosity: RUBY.

I. Bièche, F. André, C. Vicier, 2017 .

Association of COVID-19 Lockdown With the Tumor Burden in Patients With Newly Diagnosed Metastatic Colorectal Cancer

M. Ychou, E. Assenat, D. Botsen, 2021, JAMA network open.